Healthcare -
Biotechnology - NASDAQ - US
$ 0.6995
4.4 %
$ 253 M
Market Cap
-0.95
P/E
LXRX - TOTAL DEBT REPAID
Total Debt Repaid LXRX - Lexicon Pharmaceuticals, Inc.
50 M
LAST VALUE
150.40%
2 YEAR CAGR
93.22%
5 YEAR CAGR
42.17%
10 YEAR CAGR